Medical Prognosis Institute

Medical Prognosis Institute A/S, a pharmacodiagnostic company, provides drug targeting, pharmaco Dx, and DNA microarray services for

Medical Prognosis Institute A/S, a pharmacodiagnostic company, provides drug targeting, pharmaco Dx, and DNA microarray services for research projects in Denmark. It offers services in the areas of drug development, individual cancer prognostication and drug sensitivity prediction, and gene/drug discovery. The company provides Chemosensitivity Predictor, a drug response predictor that is applied to existing chemotherapeutic drugs on the market to treat cancer, as well as offers analysis and bioinformatics interpretation services. Medical Prognosis Institute A/S was founded in 2004 and is based in Horsholm, Denmark.